DEL phenotype

Immunohematology

Volumn 33, Issue 3, 2017, Pages 125-132

  Kwon, Dong Hyang ^a   Gerald Sandler, S ^b   Flegel, Willy Albert ^b,c  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Blood group antigens; Blood transfusion; DEL; RHD variants; Weak D phenotype

Indexed keywords

RHESUS D ANTIBODY; BLOOD GROUP ANTIGEN;

ALLELE; ALLOIMMUNIZATION; CAUCASIAN; EAST ASIAN; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; HUMAN; PHENOTYPE; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; UNITED STATES; BLOOD DONOR; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; FEMALE; PREGNANCY; ANCESTRY GROUP; CHINA; GENETIC ASSOCIATION; GENOTYPE; HAN CHINESE; JAPAN; KOREA; TAIWAN;

ALLELES; BLOOD DONORS; BLOOD TRANSFUSION; FEMALE; HUMANS; PHENOTYPE; PREGNANCY; RH-HR BLOOD-GROUP SYSTEM;

EID: 85058609879     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. el? Transfusion 1984;24:542.
2. Okubo Y, Seno T, Yamano H, et al. Partial D antigens disclosed by a monoclonal anti-D in Japanese blood donors. Transfusion 1991;31:782.
3. el (D-elute) using polymerase chain reaction (PCR) with RHD gene-specific primers. Transfus Med 1997;7:227-31.
4. Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001;2:10.
5. Shao CP, Maas JH, Su YQ, et al. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang 2002;83:156-61.
6. Shao CP. Transfusion of RhD-positive blood in “Asia type” DEL recipients. N Engl J Med 2010;362:472-3.
7. Singleton BK, Green CA, Kimura K, et al. Two new RHD mutations associated with the Del phenotype (abstract). Transfus Clin Biol 2001;8(Suppl 1):9s.
8. Dunnen JT, Dalgleish R, Maglott DR, et al. HGVS recommendations for the description of sequence variants: 2016 Update. Human Mutat 2016;37:564-9.
9. el individuals. Am J Clin Pathol 2004;122:193-8.
10. Shao CP, Xu H, Xu Q, et al. Antenatal Rh prophylaxis is unnecessary for “Asia type” DEL women. Transfus Clin Biol 2010;17:260-4.
11. Chang JG, Wang JC, Yang TY, et al. Human RhD el is caused by a deletion of 1013 bp between introns 8 and 9 including exon 9 of RHD gene (letter). Blood 1998;92:2602-4.
12. Luettringhaus TA, Cho D, Ryang DW, Flegel WA. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors. Transfusion 2006;46:2128-37.
13. Wagner FF. RHD PCR of D-negative blood donors. Transfus Med Hemother 2013;40:172-81.
14. Wagner FF, Flegel WA. The rhesus site. Transfus Med Hemother 2014;41357-63. (The human RhesusBase, version 2.0. http://www.rhesusbase.info/, update 2017-02-19.)
15. Shao C, Wang B, Ye S, et al. DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness. J Zhejiang Univ Sci B 2012;13:913-8.
16. Yang HS, Lee MY, Park TS, et al. Primary anti-D alloimmunization induced by “Asian type” RHD (C.1227G>A) DEL red cell transfusion. Ann Lab Med 2015;35:554-6.
17. Li Q, Hou L, Ye LY, et al. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai. Vox Sang 2009;97:139-46.
18. Ji YL, Van der Schoot CE. Red blood cell genotyping in China. ISBT Sci Ser 2016;11:55-68.
19. Gu J, Wang X, Shao C, et al. Molecular basis of DEL phenotype in the Chinese population. BMC Med Gen 2014;15:54.
20. Yang YE, Wang YH, Chen JC, et al. Prevalence of RHD1227A and hybrid rhesus in the general Chinese population. Translat Res 2007;149:31-6.
21. Okuda H, Kawano M, Iwamoto S, et al. The RHD gene is highly detectable in RhD-negative Japanese donors. J Clin Invest 1997;100:373-9.
22. Kim YJ, Kim YS, Kim C, et al. Molecular characterization of D- Korean persons; development of a diagnostic strategy. Transfusion 2005;45:345-52.
23. Kim K, Kim K, Wook K, et al. Primary anti-D immunization by DEL red blood cells. Korean J Lab Med 2009;29:361-5.
24. Flegel WA, Zabern IV, Wagner FF. Six years' experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfusion 2009;49:465-71.
25. Daniels G. Human blood groups. 2nd ed. Malden, MA: Blackwell Science, 2002.
26. Wagner FF, Ladewig B, Angert KS, Heymann GA, Eicher NI, Flegel WA. The DAU allele cluster of the RHD gene. Blood 2002;100:306-11.
27. Mak KH, Yan KH, Cheng SS, Yuen MY. Rh phenotypes of Chinese blood donors in Hong Kong, with special reference to weak D antigens. Transfusion 1993;33:348-51.
28. Wagner T, Körmöczi GF, Buchta C, et al. Anti-D immunization by DEL red blood cells. Transfusion 2005;45:520-6.
29. von Zabern I, Flegel WA. IVS5-38del4 deletion in the RHD gene does not cause a DEL phenotype: relevance for RHD alleles including DFR-3. Transfusion 2007;47:1552-5.
30. Yasuda H, Ohto H, Sakuma S, et al. Secondary anti-D immunization by Del red blood cells. Transfusion 2005;45:1581-4.
31. Körmöczi GF, Gassner C, Shao CP, et al. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion 2005;45:1561-7.
32. Flegel WA. Response to: Are weak D RBCs really immunogenic? (letter). Transfusion 2006;46:1063-4.
33. Wang QP, Dong GT, Wang XD, et al. An investigation of secondary anti-D immunization among phenotypically RhD-negative individuals in the Chinese population. Blood Transfus 2014;12:238-43.
34. Wang M, Wang BL, Xu W, et al. Anti-D alloimmunization in pregnant women with DEL phenotype in China. Transfus Med 2015;25;163-9.
35. Xu W, Zhu M, Wang BL, et al. Prospective evaluation of a transfusion policy of RhD-positive red blood cells into DEL patients in China. Transfus Med Hemother 2015;42:15-21.
36. Gardener GJ, Legler TJ, Hyett JA, et al. Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype. Transfusion 2012;52:2016-9.
37. Wang YH, Chen JC, Lin KT, et al. Detection of RhD(el) in RhD-negative persons in clinical laboratory. J Lab Clin Med 2005;146:321-5.
38. Seo MH, Won EJ, Hong YJ, et al. An effective diagnostic strategy for accurate detection of RhD variants including Asian DEL type in apparently RhD-negative blood donors in Korea. Vox Sang 2016;111:425-30.
39. Ogasawara K, Suzuki Y, Sasaki K, et al. Molecular basis for D-Japanese: identification of novel DEL and D-alleles. Vox Sang 2015;109:359-65.
40. Gu J, Wang X, Shao C, et al. Molecular basis of DEL phenotype in the Chinese population. BMC Med Genet 2014;15:54.
41. Li Q, Ye LY, Guo ZH, Zhang YX, et al. Molecular basis of D variants between Uigur and Han blood donors in Xinjiang. Transfus Med 2008;18:199-203.
42. Wu JJ, Hong XZ, Xu XG, et al. RHD 1227A allele frequency among Rh negative population and random population. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006;14:1234-7.
43. Hoeffel EM, Rastogi S, Kim MO, Shahid H. The Asian population: 2010. Suitland, MD: United States Census Bureau, 2010.
44. Wu X, Wu D, Wang M, et al. Analysis of frequency of a RHD1227A allele in Chinese Hans (abstract). Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2014;31:793-6.
45. Li JH, Zhang CY, Sun LH, Liu J. Molecular mechanisms of RhDel phenotype in blood donation population of Chinese Harbin area (abstract). Zhongguo Shi Yan Xue Ye Xue Za Zhi (Chinese) 2012;20:1478-81.
46. Chen Q, Li M, Li M, et al. Molecular basis of weak D and DEL in Han population in Anhui Province, China (abstract). Chin Med J (Engl) 2012;125:3251-5.
47. el phenotype in Taiwan. Ann Clin Lab Sci 2008;38:258-63.
48. Yazer MH, Vassallo R, Delaney M, et al. Trends in age and red blood cell donation habits among several racial/ethnic minority groups in the United States. Transfusion 2017;57:1644-55.
49. Yazer MH, Delaney M, Germain M, et al. Trends in US minority red blood cell unit donations. Transfusion 2017;57:1226-34
50. Flegel WA, Castilho SL, Keller MA, et al. Molecular immunohematology round table discussions at the AABB Annual Meeting, Philadelphia 2014. Blood Transfus 2016; 14:425-33.
51. Garratty G. Do we need to be more concerned with weak D antigens? Transfusion 2005;45:1547-51.
52. Denomme GA, Flegel WA. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion 2008;48:2461-75.